1. Home
  2. VTRS vs DTM Comparison

VTRS vs DTM Comparison

Compare VTRS & DTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VTRS
  • DTM
  • Stock Information
  • Founded
  • VTRS 1961
  • DTM 2021
  • Country
  • VTRS United States
  • DTM United States
  • Employees
  • VTRS N/A
  • DTM N/A
  • Industry
  • VTRS Medicinal Chemicals and Botanical Products
  • DTM Oil & Gas Production
  • Sector
  • VTRS Health Care
  • DTM Utilities
  • Exchange
  • VTRS Nasdaq
  • DTM Nasdaq
  • Market Cap
  • VTRS 11.8B
  • DTM 10.6B
  • IPO Year
  • VTRS N/A
  • DTM N/A
  • Fundamental
  • Price
  • VTRS $10.50
  • DTM $105.27
  • Analyst Decision
  • VTRS Hold
  • DTM Buy
  • Analyst Count
  • VTRS 5
  • DTM 12
  • Target Price
  • VTRS $10.40
  • DTM $109.17
  • AVG Volume (30 Days)
  • VTRS 9.3M
  • DTM 683.4K
  • Earning Date
  • VTRS 11-06-2025
  • DTM 10-28-2025
  • Dividend Yield
  • VTRS 4.57%
  • DTM 3.12%
  • EPS Growth
  • VTRS N/A
  • DTM N/A
  • EPS
  • VTRS N/A
  • DTM 3.74
  • Revenue
  • VTRS $14,115,700,000.00
  • DTM $1,109,000,000.00
  • Revenue This Year
  • VTRS N/A
  • DTM $26.61
  • Revenue Next Year
  • VTRS $1.66
  • DTM $8.37
  • P/E Ratio
  • VTRS N/A
  • DTM $28.15
  • Revenue Growth
  • VTRS N/A
  • DTM 15.28
  • 52 Week Low
  • VTRS $6.85
  • DTM $73.52
  • 52 Week High
  • VTRS $13.55
  • DTM $114.50
  • Technical
  • Relative Strength Index (RSI)
  • VTRS 61.05
  • DTM 58.59
  • Support Level
  • VTRS $10.29
  • DTM $101.72
  • Resistance Level
  • VTRS $10.61
  • DTM $105.85
  • Average True Range (ATR)
  • VTRS 0.19
  • DTM 2.03
  • MACD
  • VTRS -0.05
  • DTM 0.33
  • Stochastic Oscillator
  • VTRS 45.76
  • DTM 89.20

About VTRS Viatris Inc.

Viatris was formed in November 2020 through the combination of Upjohn, a wholly owned subsidiary of Pfizer that specialized in off-patent drugs, and Mylan, a global pharmaceutical manufacturer that focused on generic and specialty drugs. By joining forces, Viatris became one of the largest generic drug manufacturers in the world, servicing over 165 countries. Generics (commoditized and complex) and biosimilars make up roughly 40% of Viatris' total sales. The remaining 60% of sales are derived from its portfolio of legacy products, which includes Lipitor, Norvasc, Lyrica, and Viagra. While it covers more than 10 major therapeutic areas, Viatris has identified dermatology, ophthalmology, and gastroenterology as its three key areas of focus for future innovations.

About DTM DT Midstream Inc.

DT Midstream Inc is an owner, operator, and developer of natural gas midstream interstate and intrastate pipelines; storage and gathering systems; and compression, treatment, and surface facilities. It provides multiple, integrated natural gas services to customers through interstate pipelines, intrastate pipelines, storage systems, lateral pipelines and related treatment plants and compression and surface facilities, and gathering systems and related treatment plants and compression and surface facilities. The segments of the group are Pipeline and Gathering. It generates revenue from pipeline, storage, and gathering systems, substantially all of which are located in the Midwestern U.S., Eastern Canada, Northeastern U.S., and Gulf Coast regions.

Share on Social Networks: